Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Methocarbamol (Robaxin) most commonly causes drowsiness, dizziness, lightheadedness, headache, nausea or upset stomach, blurred vision, flushing, and a harmless brown, black, or green discoloration of urine, though less common effects such as confusion, fainting, slow heart rate, rash, or signs of an allergic reaction can also occur and warrant prompt medical attention. Several factors influence how strongly these effects hit you, including your dose, age, kidney or liver function, and whether you combine the drug with alcohol, opioids, or other sedating medications. See below to understand more about which reactions are expected, which ones signal a serious problem, and how long symptoms typically last. Because muscle relaxant side effects can closely mimic the very pain, injury, or nerve issue you are treating, it helps to sort out what is actually driving how you feel before changing anything. Take a free, instant, online symptom check to better understand your symptoms and get clear guidance on your next steps.
Last reviewed for medical accuracy: 09/24/2026
Methocarbamol is a muscle relaxant often prescribed to ease muscle spasms, pain and discomfort. Like all medications, it can cause side effects. Understanding what to expect can help you spot and manage issues early, without unnecessary worry.
Methocarbamol acts on the central nervous system to reduce muscle spasms. It doesn’t target the muscles themselves but dampens the nerve signals that trigger involuntary contractions. This can bring relief from acute pain—often related to injuries or strains—within 30 minutes to an hour of taking a dose.
Most people tolerate methocarbamol well, especially when used short-term. The side effects listed below occur in more than 1 in 100 patients:
Drowsiness or sedation
Feeling sleepy is the most frequently reported side effect. Avoid driving or operating heavy machinery until you know how the drug affects you.
Dizziness or lightheadedness
This can increase your risk of falls. Standing up slowly from a seated or lying position may help.
Headache
Mild to moderate headaches can occur. Drinking plenty of water and resting in a dark, quiet room may provide relief.
Nausea or upset stomach
Taking methocarbamol with food or a small snack often eases stomach discomfort.
Blurred vision
Temporary blurriness may affect your ability to read or focus. Give your eyes regular breaks.
Confusion or mental fog
You may feel a bit “out of it,” especially at higher doses or if you’re elderly.
While most side effects are mild, some require prompt medical attention. Contact your healthcare provider right away if you notice:
Allergic reactions (rare)
Symptoms include rash, hives, itching, swelling of the face, lips or throat, and difficulty breathing. These can develop even if you’ve taken methocarbamol before without issues.
Severe dizziness or fainting
May signal a drop in blood pressure or other serious issue.
Rapid or irregular heartbeat
Palpitations or an unusually fast pulse could indicate cardiovascular effects.
Jaundice (yellowing of skin/eyes)
A sign of possible liver dysfunction.
Dark urine or pale stools
These may also point to liver problems.
Difficulty urinating
Particularly in men with enlarged prostate.
Uncontrolled muscle movements or twitching
Could suggest nervous system over-stimulation.
Seizures
Though rare, methocarbamol can lower the seizure threshold in susceptible individuals.
If you experience any of these serious symptoms, stop the medication and seek medical help immediately.
Certain groups may have a higher likelihood of side effects:
Older adults
Age-related changes in drug metabolism can intensify drowsiness, confusion and risk of falls.
People with liver or kidney disease
Impaired organ function can lead to drug buildup and toxicity.
Individuals taking other sedatives or CNS depressants
Alcohol, opioids, benzodiazepines and some antihistamines can amplify methocarbamol’s sedative effects.
Pregnant or breastfeeding women
Limited data exist on safety during pregnancy and lactation. Discuss risks and benefits with your doctor.
Patients with seizure disorders
Lowered seizure threshold may heighten risk of convulsions.
Most side effects fade as your body adjusts. Here are practical tips to stay comfortable:
If side effects persist beyond a few days or interfere with daily life, reach out to your healthcare provider. They may adjust your dose or recommend an alternative muscle relaxant.
Knowing when side effects warrant professional attention can prevent complications:
Immediate medical care
For signs of allergy, severe dizziness, fainting, jaundice, dark urine, pale stools, chest pain or difficulty breathing.
Within 24 hours
For new or worsening confusion, persistent nausea/vomiting, severe headache or vision changes.
Routine follow-up
If mild side effects linger more than a week or if you’re unsure what to do.
If you’re ever in doubt about your symptoms, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide whether you need urgent care or a simple dose adjustment.
Open communication ensures you get safe, effective treatment:
Methocarbamol can be a valuable tool against painful muscle spasms, but like any medicine, it carries risks. Most people experience only mild, temporary side effects such as drowsiness, dizziness or nausea. Serious reactions are rare but demand immediate medical attention.
If you notice anything concerning—especially allergic signs, severe dizziness, jaundice or trouble breathing—stop the drug and seek help right away. For less urgent questions or persistent symptoms, speak with your doctor about adjusting your dose or exploring alternatives.
For a quick check on your symptoms and guidance on whether medical care is needed, try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Remember: this information is not a substitute for professional medical advice. Always talk to your doctor about any side effect that worries you or feels life threatening.
(References)
* Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage. 2004 Aug;28(2):140-75. doi: 10.1016/j.jpainsymman.2004.05.002. PMID: 15276195.
* See S, Ginzburg R. Choosing a skeletal muscle relaxant. Am Fam Physician. 2008 Aug 1;78(3):365-70. PMID: 18711953.
* Anastasio JD, Sharp CR. Acute aldicarb toxicity in dogs: 15 cases (2001-2009). J Vet Emerg Crit Care (San Antonio). 2011 Jun;21(3):253-60. doi: 10.1111/j.1476-4431.2011.00613.x. Epub 2011 Feb 11. PMID: 21631711.
* Ban VS, Bhoja R, McDonagh DL. Multimodal analgesia for craniotomy. Curr Opin Anaesthesiol. 2019 Oct;32(5):592-599. doi: 10.1097/ACO.0000000000000766. PMID: 31306155.
* Deloney LP, Smith Condeni M, Carter C, Privette A, Leon S, Eriksson EA. Efficacy of Methocarbamol for Acute Pain Management in Young Adults With Traumatic Rib Fractures. Ann Pharmacother. 2021 Jun;55(6):705-710. doi: 10.1177/1060028020964796. Epub 2020 Oct 12. PMID: 33045839.
* Dey S, Kopitnik NL, Vrooman BM. Alternatives to Opioids for Managing Pain. 2024 Jan. PMID: 34662057.
* Watkins B, Schuster HM, Gerwin L, Schoser B, Kröger S. The effect of methocarbamol and mexiletine on murine muscle spindle function. Muscle Nerve. 2022 Jul;66(1):96-105. doi: 10.1002/mus.27546. Epub 2022 Apr 27. PMID: 35373353.
* Miano TA, Wang L, Leonard CE, Brensinger CM, Acton EK, Dawwas GK, Bilker WB, Soprano SE, Nguyen TPP, Woody G, Yu E, Neuman M, Li L, Hennessy S. Identifying Clinically Relevant Drug-Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal Detection. Clin Pharmacol Ther. 2022 Nov;112(5):1120-1129. doi: 10.1002/cpt.2717. Epub 2022 Aug 20. PMID: 35881659; PMCID: PMC10015595.
* Al-Nasrawi AN, Al-Ibrahim MW, Aljabran SJ. Evaluating the Efficacy of Methocarbamol and Nefopam in Orthopedic Surgical Pain. Cureus. 2024 May;16(5):e59533. doi: 10.7759/cureus.59533. Epub 2024 May 2. PMID: 38707756; PMCID: PMC11066708.
* Chan E, Waggoner C, Boylan PM. Commentary: Is Polyethylene Glycol Toxicity From Intravenous Methocarbamol Fact or Fiction? J Pain Palliat Care Pharmacother. 2024 Jun;38(2):180-184. doi: 10.1080/15360288.2024.2345322. Epub 2024 May 8. PMID: 38718034.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.